Using this signature, the patients were divided into Cluster A and Cluster B. Compared with Cluster A, most cuproptosis genes (such as CCDC22, PDHA1, ARF1, and AQP1) in Cluster B were highly expressed, resulting in a better prognosis for patients with cervical cancer. The gene discussed is PDHA1; the disease is cervical carcinoma.